MARSHALL WACE, LLP - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$592,000
-46.8%
34,811
-87.9%
0.00%
-66.7%
Q3 2019$1,113,000
-46.8%
286,782
-17.4%
0.01%
-47.1%
Q2 2019$2,094,000
+711.6%
347,343
+2215.6%
0.02%
+54.5%
Q1 2018$258,000
-97.4%
15,000
-93.7%
0.01%
-88.0%
Q4 2015$9,841,000
+285.5%
237,141
+43.0%
0.09%
+196.8%
Q3 2015$2,553,000165,8790.03%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Eventide Asset Management 1,085,200$44,873,0002.75%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 328,329$13,576,0000.94%
HAYS ADVISORY LLC 135,722$5,612,0000.87%
AWM Investment Company, Inc. 90,000$3,721,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 448,000$18,525,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 60,000$2,481,0000.64%
RTW INVESTMENTS, LP 44,701$1,848,0000.63%
Telemetry Investments, L.L.C. 26,000$1,075,0000.58%
Spark Investment Management LLC 148,100$6,123,0000.57%
Perceptive Advisors 169,439$7,006,0000.49%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders